“The Man Who Called Nvidia at 11 Cents Says a New Company Will Become The Next Trillion Dollar Stock” is the headline from Alexander Green's promotion for The Oxford Club. It points readers toward a new AI winner hiding behind the next big technology wave.
The sales pitch expands that idea into seven AI stocks, including one supposedly tied to an Apple agreement running through 2040 and another where NVIDIA is said to be investing hundreds of millions of dollars. A $7,000 portfolio, the promotion says, could make you a millionaire in less than six years if bought before the end of the month.
The headline stock is Arm Holdings plc, ticker ARM. We identify it with 95/100 confidence; the broader promotion is a seven-stock basket, not a single secret company.
What the pitch tells you without telling you
The strongest clues are unusually specific. The company only IPO'd in 2023, says its technology has shipped in more than 280 billion chips, gets about 60% of its revenue from royalties and reported an $824 million quarter. Its IPO prospectus also describes an Apple agreement extending beyond 2040 and names NVIDIA among investors that indicated interest in the offering.
The same pitch is also branded as “The NEXT Trillion Dollar Stock,” “Next Magnificent Seven,” “AI super stocks,” “The Next Magnificent Seven Stocks,” “The NEXT Magnificent Seven,” “Next Magnificent Seven portfolio” and “Next Magnificent Seven Stock.” These are different labels for the same Oxford Club idea, not separate discoveries.
The stocks behind The Next Magnificent Seven
The headline pick is Arm Holdings plc (NASDAQ: ARM). Arm designs the CPU architecture and related intellectual property used throughout the chip industry, making it a natural fit for an AI infrastructure pitch. The company's IPO prospectus confirms that Apple's access to the Arm architecture extends beyond 2040, while Arm's investor presentation says more than 280 billion Arm-based chips had shipped since inception.
The clues line up beyond the Apple reference. Arm's FY2024 Form 20-F reports $1.675 billion in royalty revenue on $2.679 billion of total revenue, or about 62.5%. Its Q3 FY2024 shareholder letter reported $824 million in quarterly revenue and guided to roughly $3.2 billion for the year. That combination is too distinctive to confuse with another member of the basket.
The other six names are Cloudflare, ASML, Palantir, Symbotic, CyberArk and CRISPR Therapeutics. Oxford Club's later Next Magnificent Seven update confirms the same seven-company lineup, while the company-specific clues fit their assigned areas: cloud infrastructure, semiconductor equipment, enterprise software, warehouse robotics, cybersecurity and gene editing. All seven were pinned down, but the evidence quality varies sharply from one member to the next.
| # | Ticker | Company | Our confidence |
|---|
| Main pick | ARM | Arm Holdings plc | 95/100 — high |
| 2 | NET |
Checking the pitch against the filings
The claim-by-claim table below puts 117 promotional statements beside the relevant filings, investor materials, company announcements and market data. That distinction matters here: several clues are solid, while the sales copy stretches others well past what the documents actually say.
ARM — Arm Holdings plc
| The promotion claims | Verdict | What we found |
|---|
| A mega-contract with Apple puts the company's AI technology in the iPhone through 2040 | Overstated | Arm's IPO prospectus confirms a new Apple agreement extending beyond 2040, but describes continued access to the Arm architecture rather than an AI-technology contract specifically for iPhones. |
| One Next Magnificent Seven stock signed a major Apple deal putting its AI technology in iPhones and iMacs until 2040 | Overstated | Arm's IPO prospectus confirms the Apple relationship extends beyond 2040, but does not specify iPhones, iMacs or an AI-technology placement. |
|
NET — Cloudflare, Inc.
| The promotion claims | Verdict | What we found |
|---|
| Cloudflare has more than 300 data centers located in cities across the world | Overstated | Cloudflare's network page reports 337 cities and its About page reports 335 cities, but the company describes cities and network locations rather than exactly more than 300 data centers. |
| Cloudflare is the fastest network provider in most of the world's countries | Contradicted | Cloudflare's own performance update said it was fastest in 40% of the largest 1,000 networks, which does not support being fastest in most countries. |
|
| The promotion claims | Verdict | What we found |
|---|
| ASML was founded in 1984 and is based in the Netherlands | Checks out | ASML's corporate profile says it was founded in 1984 and is headquartered in Veldhoven, the Netherlands. |
| ASML's machines are the size of a bus |
PLTR — Palantir Technologies Inc.
| The promotion claims | Verdict | What we found |
|---|
| Palantir was hired by Ferrari | Checks out | Ferrari announced that it renewed its partnership with Palantir and that Scuderia Ferrari would use the Palantir Foundry platform. |
| Palantir was hired by Cleveland Clinic | Checks out | Cleveland Clinic's State of the Clinic report describes its collaboration with Palantir, including capacity-management and hospital-operations work. |
|
SYM — Symbotic Inc.
| The promotion claims | Verdict | What we found |
|---|
| Symbotic develops AI software and robotics for U.S. supply chains | Checks out | Symbotic's FY2025 Form 10-K describes proprietary robotics and AI-powered software for warehouse supply-chain operations. |
| Symbotic robots can navigate distribution centers at speeds up to 20 mph | Checks out | Symbotic's FY2025 Form 10-K says its bots can exceed 20 mph and that some can reach up to 25 mph. |
|
CYBR — CyberArk Software Ltd.
| The promotion claims | Verdict | What we found |
|---|
| The cybersecurity company has more than 8,000 customers | Checks out | CyberArk's 2023 annual report says its customer count rose from more than 8,000 at December 31, 2022 to more than 8,800 at December 31, 2023. |
| American Express is a CyberArk customer | Checks out | CyberArk's customer announcement records American Express among its customers, although the cited reference is historical. |
|
CRSP — CRISPR Therapeutics AG
| The promotion claims | Verdict | What we found |
|---|
| CRISPR Therapeutics was the first company ever to win full approval of a gene-editing drug | Overstated | The FDA calls CASGEVY the first FDA-approved CRISPR/Cas9 therapy, but the treatment was developed with Vertex, so attributing the historic approval solely to CRISPR Therapeutics overstates the record. |
| CRISPR Therapeutics has two treatments in development for cardiovascular disease | Checks out | CRISPR Therapeutics' investor materials list CTX310 and CTX320 cardiovascular programs. |
|
Claims about the pitch itself
| The promotion claims | Verdict | What we found |
|---|
| Each of the seven companies possesses patented technology for technology, healthcare, manufacturing and internet applications | Can't verify | The Oxford Club sales page uses broad patented-technology language, but the record reviewed does not establish that every one of the seven has patented technology covering all four named application areas. |
| The offer features seven little-known stocks associated with artificial intelligence | Overstated | The market quoted ARM at roughly $296 billion, at $105 billion, at $653 billion and at $366 billion, with averaging about 40.6 million shares a day, making little-known an exaggerated description. |
Claims the record contradicts
“Cloudflare is the fastest network provider in most of the world's countries” — Cloudflare's own performance update said it was fastest in 40% of the largest 1,000 networks, which does not support being fastest in most countries.
“Cloudflare's third-quarter net income improved 167%” — Cloudflare's Q3 2023 release reported non-GAAP net income of $55.3 million versus $19.1 million, a roughly 190% increase rather than 167%.
“Symbotic has $675 million in cash” — Symbotic's FY2023 results reported approximately $724.8 million of cash, cash equivalents and restricted cash, not $675 million.
“Symbotic insiders own 19% of outstanding shares” — Current ownership records put Symbotic insider ownership at about 13.9%, and the company's beneficial-ownership disclosures reviewed do not support a 19% figure.
Where the pitch outran the record
“A mega-contract with Apple puts the company's AI technology in the iPhone through 2040” — Arm's IPO prospectus confirms a new Apple agreement extending beyond 2040, but describes continued access to the Arm architecture rather than an AI-technology contract specifically for iPhones.
“One Next Magnificent Seven stock signed a major Apple deal putting its AI technology in iPhones and iMacs until 2040” — Arm's IPO prospectus confirms the Apple relationship extends beyond 2040, but does not specify iPhones, iMacs or an AI-technology placement.
“The offer features seven little-known stocks associated with artificial intelligence” — The market quoted ARM at roughly $296 billion, NET at $105 billion, ASML at $653 billion and PLTR at $366 billion, with PLTR averaging about 40.6 million shares a day, making little-known an exaggerated description.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Get Started →The deadline, examined
The deadline is attached to buying the proposed $7,000 portfolio before the end of the month, not to a disclosed earnings date, FDA decision or other corporate event. We received this promotion on only one day, August 4, 2026, so the record is too thin to judge whether the deadline rolls.
For now, the honest description is simple: one observed mailing announced a month-end cutoff. There isn't enough history to say how long that cutoff lasts.
Worth owning, or just worth pitching?
The pitch's central claim is that AI will reshape the economy, these seven companies supply the essential technology, and a $7,000 basket can become a million dollars in less than six years. The first link holds better than the last. These are real businesses with real AI exposure, customer relationships and growth examples, but the millionaire outcome is a stock-price forecast dressed up as a conclusion.
Arm is a credible AI infrastructure business, and ASML is a uniquely positioned supplier of the equipment needed to make advanced chips. Palantir has documented government and commercial deployments, while Cloudflare and CyberArk provide software and security exposure. Symbotic adds warehouse automation, and CRISPR Therapeutics brings a much more clinical, binary biotechnology risk. That isn't one uniform theme; it's a bundle of very different bets.
The weakest link is the leap from useful technology to inevitable wealth. The Apple evidence supports continued access to Arm's architecture beyond 2040, not an AI-technology contract specifically putting Arm inside iPhones and iMacs. The NVIDIA evidence is narrower still: Arm's prospectus describes an indication of interest from a cornerstone-investor group totaling up to $735 million, without disclosing NVIDIA's individual amount. The promotion turns two real disclosures into a much larger story.
On the merits, the basket has substance, but it doesn't deserve to be treated as seven interchangeable lottery tickets. Arm and ASML carry the clearest semiconductor infrastructure case; Palantir adds a strong applied-software angle. Cloudflare, CyberArk and Symbotic have credible operating businesses with different execution risks, while CRISPR depends far more on clinical and regulatory progress. The companies can be worth examining. The six-year millionaire promise cannot.
How confident are we? ARM 95, NET 88, ASML 92, PLTR 96, SYM 82, CYBR 84, CRSP 88 out of 100. We identified 7 stocks from the promotion's own clues and checked 117 claims across them against filings, earnings calls, ownership records, market data and public reporting. Confidence is scored per stock, so a weaker one does not borrow credit from a stronger one. This is our analysis, not the publisher's disclosure — we have no relationship with them.